Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Draupnir Bio ApS
APS
Active
Reklamebeskyttelse
CVR 38546880
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 9 years old
12 employees
www.draupnir.bio
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Draupnir Bio ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
13M
26M
39M
52M
0M
2021
0M
2022
0M
2023
0M
2024
45M
2025
EBITDA
DKK millions
0M
-22M
-44M
-66M
-88M
-70M
2021
-43M
+39%
2022
-44M
-2%
2023
-44M
0%
2024
-7M
+84%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
—
—
—
—
45.120
Staff expenses
-23.292
-22.795
-17.104
-21.224
-13.288
EBITDA
-69.985
-42.607
-44.023
-43.751
-7.249
Depreciation & amort.
-1.767
-2.430
-2.413
-2.398
-2.269
EBIT
-71.752
-45.037
-46.436
-46.149
-9.518
Net financials
-665
-449
-81
406
-4.680
Profit before tax
-72.417
-45.486
-46.518
-45.743
-14.198
Tax
-5.373
-5.596
-5.352
-5.430
-1.888
Net profit
-67.044
-39.890
-41.166
-40.314
-12.310
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
67.865
28.383
36.192
35.033
39.072
Equity
53.466
18.566
29.386
27.633
15.256
Long-term debt
3.766
2.632
1.416
112
3.172
Short-term debt
8.987
7.185
5.390
7.287
20.644
Total debt
12.753
9.817
6.806
7.399
23.816
Financial ratios
5-year trend
EBITDA-margin
-16.1%
This company
15.8%
Market median
-202% vs market
2021
2025
Soliditetsgrad
39.0%
This company
38.2%
Market median
+2% vs market
2021
2025
Egenkapitalforrentning
-80.7%
This company
18.4%
Market median
-539% vs market
2021
2025
Nettoresultatgrad
-27.3%
This company
8.1%
Market median
-437% vs market
2021
2025
Aktivomsætning
1.15×
This company
1.12×
Market median
+3% vs market
2021
2025
Gæld/egenkapital
1.56×
This company
0.62×
Market median
-152% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Draupnir Bio ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
